Literature DB >> 16641423

Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography.

C-S Li1, R-C Chen, H-Y Tu, L-S Shih, T-A Zhang, J-M Lii, W-T Chen, S-J Duh, L-C Chiang.   

Abstract

To investigate the imaging appearance of well-differentiated hepatocellular carcinoma (HCC) on dynamic CT, a total of 38 histopathologically proven well-differentiated HCC were included in a retrospective study. We reviewed the contrast-enhanced dynamic CT of all 38 tumours for attenuation of each tumour in unenhanced scan, arterial-dominant and delayed portal venous phases. Our results showed that dynamic CT identified 26 (68.4%) out of the 38 lesions. The remaining 12 lesions were isodense compared with surrounding liver parenchyma in each dynamic CT phase. There was no statistically significant difference between the mean size of tumours detected by dynamic CT and that of tumours not detected by dynamic CT (p = 0.1). Of a total of 38 tumours, most were isodense (n = 19) or hypodense (n = 16) in unenhanced scan, mostly hyperdense (n = 18) or isodense (n = 15) in arterial-dominant phase and mostly isodense (n = 22) or hypodense (n = 15) in delayed portal venous phase. Enhancement of tumour was observed in 19 (50.0%) of 38 lesions. In conclusion, the ability of dynamic CT to detect well-differentiated HCC is poor, and negative CT findings cannot exclude the presence of well-differentiated HCC, especially if there is well-grounded clinical suspicion for HCC.

Entities:  

Mesh:

Year:  2006        PMID: 16641423     DOI: 10.1259/bjr/12699987

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

1.  Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI.

Authors:  H Rhee; M-J Kim; M-S Park; K A Kim
Journal:  Br J Radiol       Date:  2012-05-02       Impact factor: 3.039

2.  Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule.

Authors:  Kazuhiro Saito; Fuminori Moriyasu; Katsutoshi Sugimoto; Ryota Nishio; Toru Saguchi; Toshitaka Nagao; Junichi Taira; Soichi Akata; Koichi Tokuuye
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

3.  Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging.

Authors:  Chen-Te Chou; Jung-Mao Chou; Ting-An Chang; Shiu-Feng Huang; Chia-Bang Chen; Yao-Li Chen; Ran-Chou Chen
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

4.  CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase.

Authors:  Akihiro Nishie; Kengo Yoshimitsu; Daisuke Okamoto; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Daisuke Kakihara; Tomohiro Nakayama; Yukihisa Takayama; Ken Shirabe; Nobuhiro Fujita; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2012-10-17       Impact factor: 2.374

5.  Enhancement patterns of hepatocellular carcinomas on multiphasicmultidetector row CT: comparison with pathological differentiation.

Authors:  J H Lee; J M Lee; S J Kim; J H Baek; S H Yun; K W Kim; J K Han; B I Choi
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

6.  SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.

Authors:  Seong Hyun Kim; Won Jae Lee; Hyo K Lim; Cheol Keun Park
Journal:  Korean J Radiol       Date:  2009-03-03       Impact factor: 3.500

7.  Multiphase convolutional dense network for the classification of focal liver lesions on dynamic contrast-enhanced computed tomography.

Authors:  Su-E Cao; Lin-Qi Zhang; Si-Chi Kuang; Wen-Qi Shi; Bing Hu; Si-Dong Xie; Yi-Nan Chen; Hui Liu; Si-Min Chen; Ting Jiang; Meng Ye; Han-Xi Zhang; Jin Wang
Journal:  World J Gastroenterol       Date:  2020-07-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.